Status:
NOT_YET_RECRUITING
Gastroesophageal Reflux Disease Diagnostic Trial
Lead Sponsor:
Changhai Hospital
Collaborating Sponsors:
West China Hospital
Ruijin Hospital
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18-85 years
Brief Summary
Gastroesophageal reflux disease (GERD) is a very common condition in clinical practice. In China, GERD affects nearly 150 million patients, whose quality of life are seriously impacted. Currently, the...
Eligibility Criteria
Inclusion
- ≥18 years and ≤85 years, male or female;
- A visit was made for symptoms such as persistent reflux, heartburn, bloating, early satiety, and belching;
- Patients volunteered to participate in the clinical trial, signed an informed consent form, and were able to cooperate with clinical follow-up.
Exclusion
- History of esophageal surgery;
- Presence of dysphagia, esophagogastric fundal varices, or esophageal stenosis;
- Presence of coagulation disorders or taking anticoagulant or antiplatelet drugs;
- Those with a life expectancy of less than 5 years;
- Persons with mental anomalies who are incapable of behavioral autonomy;
- Other conditions that, in the judgment of the physician, preclude participation in the trial.
Key Trial Info
Start Date :
July 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06504134
Start Date
July 30 2024
End Date
December 31 2027
Last Update
July 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.